Highlights
1 patentProfile claimed by owner
About
Continuous Stroke-prevention Device for High-risk Patients
InVatin Technologies has developed SYNAXIS-XT, an aortic arch uni-axial diverter designed to deliver embolic protection to the three arteries ascending from the aortic arch, thereby minimizing the risk for cerebral ischemic stroke. The company's device provides a mechanical barrier, redirecting the emboli away from the brain while preserving blood flow patterns and maintaining uncompromised stent patency. This technology can help prevent stroke in high-risk patients, regardless of the origin of the embolic substance.
Identity
| Name | Invatin Technologies |
|---|---|
| Slug | invatin-technologies |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4NzbsNMIDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Mar 2022 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | North District |
| HQ city | Qatsrin |
| HQ address | Barnea St Galil Ofek Building Katzrin Industry Park 1290000 |
Web & social
| https://www.linkedin.com/company/invatin-technologies-ltd/about |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProvidersPatients
Business models
B2B
Tags
cardiovascularhospitalsmedical-technologiesdoctorsmedical-devicescardiologystentsurgerystrokeprevention
Funding
| Total raised | — |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}